Category Archives: Anxiety

CES Ultra is a non-drug approach to treatment of anxiety

Brain Stimulation Therapies for Mental Health

Alternatives to Drugs in the Treatment of Depression

It’s estimated that around 30 percent of people with depression don’t respond to typical antidepressants. This is known as treatment-resistant depression. An important alternative which can be life-changing is brain stimulation therapy.

brain-stimulation-for-mental-health

Brain stimulation therapy involves the application of [electric] energy over specific brain regions to modulate the function of neural circuits. This can help alleviate symptoms of depression or other mental illnesses that aren’t responding to typical treatments, such as bipolar disorder. There are five main types of brain stimulation therapies used to treat mental illness: electroconvulsive therapy, vagus nerve stimulation, deep brain stimulation, repetitive transcranial magnetic stimulation, and magnetic seizure therapy. Let’s explore vagus nerve stimulation(VNS) and Deep brain stimulation (DBS).

Vagus nerve stimulation (VNS)

Vagus nerve stimulation was initially developed as a treatment for the seizure disorder epilepsy, and in a happy accident, scientists discovered that it could help with depression as well. The FDA approved VNS for treatment-resistant depression in 2005.

If you’re getting this kind of therapy, doctors will surgically implant a tool called a pulse generator into the upper left portion of your chest. An electrical wire connects the pulse generator to your vagus nerve, which runs from your brain through your neck and into your chest and abdomen. From its command center in your chest, the pulse generator will send bursts of electric currents to your brain every couple of minutes. Pulse generators typically work for around 10 years before they need to be replaced.

It appears as though VNS can improve issues like severe depression by changing levels of neurotransmitters in your brain including serotonin, norepinephrine, GABA, and glutamate. A 2018 study published in The Journal of Clinical Psychiatry analyzed quality of life reports from 599 people with treatment-resistant depression, finding that those who combined VNS with other antidepressant treatments experienced significant improvements in their quality of life, even if their symptoms didn’t disappear completely. That points to an important fact about VNS: anyone receiving it will need to continue their other treatments (like taking antidepressants). Even so, it can take months to see a difference when using VNS, and the device could shift or malfunction, which may require more surgery.

VNS is not a surefire fix. Some people’s conditions get worse after they try it, not better.

Deep brain stimulation (DBS)

This started as a treatment for Parkinson’s disease, according to the American Association of Neurological Surgeons. Then doctors realized it shows promise for easing depression and obsessive compulsive disorder, too. FDA approved deep brain stimulation for obsessive compulsive disorder, but not yet for depression.

Like VNS, deep brain stimulation uses pulse generators in the chest to send electrical pulses to the brain. Unlike VNS, which delivers stimulation in bursts, DBS involves more continuous stimulation but you should be able to customize the exact frequency with your doctor’s help.

The Problem: Both Deep brain stimulation and Vagus nerve stimulation describe costly and intrusive procedure involving an implant.

The Solution:

There is another non –intrusive, non-invasive and  way to target the vague nerve: cranial electrotherapy stimulation using CES devices. CES devices can achieve good result at fraction of the cost; and there is no need for an implant.CES therapy is simple and easy. Pre-gelled electrodes are placed in such a manner as to directly The compact size and ear clip electrodes makes it easy to use just about anywhere and under a variety of circumstances. You can your portable CES unit  at home while watching TV, doing the dishes, walking, studying, at the office while poring over a report, etc. You can do so safely, with no serious negative side-effects and at a fraction of the cost and none of the risks of a major operation.

re: > https://www.self.com/story/brain-stimulation-therapies

Anti-anxiety pills could be next U.S. drug epidemic

Anxiety disorders are the most common mental illness in the U.S., affecting 40 million adults in the United States age 18 and older, or 18.1% of the population every year.

anti-anxiety-pills

Considered relatively safe and non-addictive by consumers and many doctors, Xanax, Valium, Ativan and Klonopin have been prescribed to millions of Americans for decades to calm jittery nerves and promote a good night’s sleep. But the number of people taking the sedatives and the average length of time they’re taking them have shot up since the 1990s, when doctors also started liberally prescribing opioid painkillers.

Actually anti-anxiety pills are not so safe. Due to their high potency, benzodiazepines can change the brain’s neurochemistry. Over time, the drugs build up in the user’s body. Users can develop mental and physical dependencies on the drugs as a result.

Prescriptions have increased more than 60 percent in the last two decades and overdose deaths involving them have more than quadrupled between 2002 and 2015, promptings some states to limit the number of pills a patient can be prescribed.

The growing use of anti-anxiety pills reminds some doctors of the early days of the opioid crisis. Benzodiazepines, or “benzos,” are a class of pharmaceutical drugs prescribed for a spectrum of mental disorders and ailments. They are used to treat moderate to severe anxiety, panic attacks, epileptic seizures and even withdrawal symptoms from other central nervous system depressants like alcohol. Benzodiazepines are legal when they are prescribed. However, a black market for the drugs exists as well. On the street, benzodiazepine drugs might go by other names like tranks, downers or simply benzos.

State and federal officials are now warning that excessive prescribing of a class of drugs known as benzodiazepines or “benzos” is putting more people at risk of dependence on the pills and is exacerbating the fatal overdose toll of painkillers and heroin. When taken in combination with painkillers or illicit narcotics, benzodiazepines can increase the likelihood of a fatal overdose as much as tenfold, according to the National Institute on Drug Abuse. On their own, the medications can cause debilitating withdrawal symptoms that last for months or years. As prescriptions for benzodiazepines have grown since the late 1990s, so have deaths, according to a study at Montefiore Medical Center in New York. The National Institute on Drug Abuse reports that overdose deaths involving benzodiazepines quadrupled from 2002 to 2015.

Benzodiazepines are a fantastic medication to deal with and to cope with infrequent and unnatural experiences. These anxiety drugs should only be reserved for infrequent procedures like a colonoscopy, or extensive dental procedure.

We don’t need chemicals to get us through the painful events of life. This is about a 20-30 year old phenomena in the US where we feel we need to cope with life using chemicals to get us through traumatic issues. Once It becomes a coping mechanism to deal with your life, we have to question what we are doing here.

While opioids’ toxic effects are respiratory depression, benzos also depress your breathing and can be fatal. The body becomes so relaxed and euphoric from drugs like Xanax, that it doesn’t feel the need to breathe, he said. Patients end up dying from an “overdose of pleasure.” In a lot of ways benzos mimic the pharmacology of alcohol. It impairs memory, it impairs cognitive ability, and literally lowers your IQ and ability to function.

Public health officials warn that people who abruptly stop taking benzodiazepines risk seizures or even death. Opioid withdrawal will make you want to die, but typically won’t kill you. Benzo withdrawal on the other hand can create withdrawal seizures that can be life threatening.

Further statistics show:

  • 65% of North Americans take prescription medications daily, 43% take mood altering prescriptions regularly.
  • There were over 3.3 Billion prescriptions filled in America in 2002 (12 times the U.S’s population – that’s 12 prescriptions for every man, woman, and child in the U.S. that year).
  • Paxil and Zoloft (two of the more popular anti-anxiety medications) ranked 7th and 8th in the top ten prescribed medications in the US (these two medications totaled almost $5 Billion in sales in 2002).

People need to rely more on talk therapy or alternative medicine to cope with their anxiety and distress, instead of counting on a magic pill.

Cranial Electortherapy Stimulation (CES) is a safe alternative to drugs. CES is a unique and viable “bioelectric” approach which enhances the homeostasis of the biological central nervous system – the tendency for intrinsic balance within a system. Isn’t it time we examined a drug-free alternative? Cranial Electrotherapy is exactly that — an effective modality with no negative side-effect.

ref:> yellowhammernews.com/addiction-expert | health.com/anxiety | anxietycentre.com

CES Anxiety Studies

There has now been almost 40 years of experience in the U.S. of CES as a non medication treatment for anxiety.

Also noteworthy is that among the more than 2000 patients who have been involved in CES studies in the U.S there has been no significant, negative side effect reported from the use of CES. As the National Research Council reported to the FDA when asked to evaluate the safety of CES, “Review of these reports reveals that significant side effects or complications attributable to the procedure are virtually nonexistent.”

ces-table

Earlier meta-analysts completed their meta-analyses by the use of published means and standard deviations. Most authors do not report these when they publish, so that among the more than 100 CES studies published in the U.S., only 8 could be found that contained that information. Two meta-analyses were performed limited to the use of these 8 studies, one at Harvard and one at the University of Tulsa Graduate School, and both concluded that CES was unquestionably effective for the treatment of anxiety.

Very early on in the U.S. the anxiety found in the substance abstinence syndrome was treated with CES. Patients who withdraw from various addictive substances suffer intensively from anxiety, depression and sleep disturbance. Because that group has proven susceptible to cross addiction to psychoactive medications, and because they are also more resistant to the effects of most of those medications than are non-addicted patients, CES soon became a treatment of choice in both inpatient and outpatient treatment programs for this group of patients.

Luckily for CES meta-analysts, there are available journals that have a history of readily publishing negative CES studies, while on occasion refusing to publish studies with positive findings. To everyone’s surprise, journal editors (or their chosen group of peer reviewers) can be biased.

A meta-analyst has succeeded if the majority of studies that are available have been identified, since it can easily be shown statistically that unless the analyst was specifically biased in the sampling procedure, the outcome would rarely be changed importantly if the remainder of the completed studies appeared in the analysis. This point will be returned to later when the standard error of the mean and the confidence limits of the effect size is discussed.

In the field of CES the analyst has an advantage in that it is a small, tightly knit field in which most researchers know what the others are doing or have published.

Ref> Dr. Ray Smith

Antidepressants and Non-drug Alternatives

A few years ago, the Organization for Economic Cooperation and Development (OECD) looked at antidepressant use in 25 countries and found something startling. In every single country the OECD looked at, antidepressant use was on the rise.

In Germany, antidepressant use had risen 46% in just four years. In Spain and Portugal, it rose about 20% during the same period. Iceland led the pack in overall use with about one in ten people taking a daily antidepressant — but that figure may underestimate the actual rate of use, since that calculation isn’t restricted to just adults.

The United States was not included in the OECD analysis (we’ve added it to the chart below), but if it had been, it would knock Iceland out of the top spot: 11% of Americans over the age of 12 take an antidepressant.

antidepressant chart

Antidepressant use is not an accurate window into rates of depression. Instead, the popularity of antidepressants in a given country is the result of a complicated mix of depression rates, stigma, wealth, health coverage, and availability of treatment.

The OECD suggests two possible reasons the rate of antidepressant consumption is on the rise in so many countries. The course of treatment lasts longer than it used to, and antidepressants are now prescribed not only for severe depression, but also for mild depression, anxiety, social phobia, and more.

Among Americans, 60% of people taking antidepressants have been taking them for at least two years; 14% have taken them for 10 years or more.

Central-nervous-system agents today constitute the fastest growing sector of the pharmaceutical market, accounting for 31% of total sales in the United States.

This trend is fraught with danger. Some people take the wrong medication; others get an old or contaminated batch, some a counterfeit; others take them in dangerous combinations with other prescriptions. Some drugs are addictive, others have devastating emotional and physical side effects. Every year a million people—3 to 5% of all hospital admissions—are admitted primarily because of a negative reaction to medications. The situation has become especially exacerbated by the medical profession’s propensity to dole out medication like candy for the slightest sign of depression, anxiety, or insomnia, helping make drugs like Prozac, Buspar, and Paxil as chic in the suburbs as crack is in the inner city. This has led to a virtual plague of legal drug addiction.

Cranial Electrotherapy Stimulation (CES) is a safe and effective alternative for the treatment of anxiety, depression, and insomnia. CES is the anti-drug—the non-pharmacological alternative—a unique and viable bio-electric approach which enhances the homeostasis of the biological central nervous system—the tendency for intrinsic balance within a system. User-friendly, it employs mild battery-powered electrical stimulation through clip-on electrodes attached to the earlobes or pre-gelled electrodes placed behind the ears. Current flow is limited so that the most the patient experiences during the process is nothing more than a slight tingling sensation. There are virtually no negative side effects. Gently adding energy back to all parts of the brain, CES helps return the user to the optimum state in effect before stressors were activated.

CES impacts most directly by reducing anxiety. This is often experienced in the course of treatment; for others, hours, or several days after. CES leaves the patient feeling both relaxed and alert. The effect differs from pharmaceutical treatments in that people report their body as feeling lighter and more relaxed and their mind, more alert and clear. Results are cumulative and lasting. For those suffering from depression and anxiety, CES means relief with none of the unpleasant side effects of prescription drugs. For those seeking nothing more than a good night’s sleep, it is an alternative to habit-forming tranquilizers. For a public increasingly concerned with the effects of stress on physical health and emotional well being, CES provides a way of addressing that stress in a safe and effective manner.

CES is a treatment modality with an ethic – that of self-regulation. Its goal, wellness—a state of proper alignment—the balanced interplay of body and mind attained through personal empowerment rather than dependency. The CES ethic believes that increased reliance on external drugs interferes with that self-regulatory process, reducing our ability to cope. That to reclaim control of our lives we have to learn how to alter that chemical composition and reorient that circuitry, not through dependency but by activating, strengthening, and effectively employing our own inner resources. CES—a treatment modality whose time has come.

Kids on Drugs (Thanks to Parents and Doctors)

Part I: The Dangers

Part II

Parents and Doctors are often overwhelmed when having to deal with ADHD kids. They often look for a shortcut—prescription drugs. Common brand names include stimulants such as Ritalin, Concerta, Adderall, Metadate, Vyvanse, and Provigil. Use of such drugs has reached epidemic proportions. The figures are staggering:

kids-on-drugs

 

More than 1 in 10 (11%) US school-aged children had received an ADHD diagnosis by a health care provider by 2011, as reported by parents.

o    6.4 million children reported by parents to have ever received a health care provider diagnosis of ADHD , including:

  • 1 in 5 high school boys
  • 1 in 11 high school girls

 

The percentage of US children 4-17 years of age with an ADHD diagnosis by a health care provider, as reported by parents, continues to increase.

o    A history of ADHD diagnosis by a health care provider increased by 42% between 2003 and 2011:

  • 7.8% had ever had a diagnosis in 2003
  • 9.5% had ever had a diagnosis in 2007
  • 11.0% had ever had a diagnosis in 2011

o    Average annual increase was approximately 5% per year

The percentage of children 4-17 years of age taking medication for ADHD, as reported by parents, increased by 28% between 2007 and 2011.

o    Percentage of children taking medication for ADHD was:

  • 4.8% in 2007
  • 6.1% in 2011

o    Average annual increase was approximately 7% per year

The average age of ADHD diagnosis was 7 years of age, but children reported by their parents as having more severe ADHD were diagnosed earlier.

o    8 years of age was the average age of diagnosis for children reported as having mild ADHD

o    7 years of age was the average age of diagnosis for children reported as having moderate ADHD

o    5 years of age was the average age of diagnosis for children reported as having severe ADHD

More US children were reported by their parents to be receiving ADHD treatment in 2011 compared to 2007, however treatment gaps may exist.

o    In 2011, as many as 17.5% of children with current ADHD were reported by their parents as not receiving either medication for ADHD or mental health counseling

o    More than one-third of children reported by their parents as not receiving treatment were also reported to have moderate or severe ADHD

The patterns in ADHD diagnosis and medication treatment showed increases in the percentages overall, however some new patterns emerged between 2007 and 2011.

o    The percentage of children reported by their parents to have a history of health care provider diagnosed ADHD increased for most demographic groups (for example, across racial groups, boys and girls) from 2003 to 2011; however,

o    Between 2007 and 2011, the percentage of children reported by their parents to have a history of a health care provider diagnosed ADHD:

  • Was similar among older teens
  • Decreased among multiracial children and children of other races when compared to black or white children

The number of US families impacted by ADHD continues to increase.

o    An estimated 2 million more children were reported by their parents to be diagnosed by a health care professional with ADHD in 2011, compared to 2003

  • By 2011, 6.4 million children were reported by their parents to be diagnosed by a health professional with ADHD compared to 4.4 million in 2003

o    An estimated 1 million more children were reported by their parents to be taking medication for ADHD in 2011, compared to 2003.

  • By 2011, 3.5 million children were reported by their parents to be taking medication for ADHD compared to 2.5 million in 2003

kids-adhd-drugs

These figures should give pause for consideration. By increasing children’s dependence on pharmaceuticals, they learn that the best and easiest way to deal with their emotional issues is by taking a drug, perfect training for their adult years and an added incentive to graduate to recreational drug use and an increased reliance and dependence on prescriptions as a pathway to health.

ADHD Drug Warnings:

There have been 44 warnings from eight countries (United States, United Kingdom, Canada, Japan, Australia, New Zealand, France and Singapore) warning that ADHD drugs/stimulants cause harmful side effects. These include the following (note that some warnings cite more than one side effect, so the list below may not be equal to the total number of warnings):

  • 13 warnings on stimulants causing heart problems
  • 10 warnings on stimulants causing mania/psychosis
  • 9 warnings on stimulants causing cardiovascular problems
  • 8 warnings on stimulants causing death
  • 4 warnings on stimulants causing hallucinations
  • 4 warnings on stimulants causing depression
  • 4 warnings on stimulants causing violence, hostility or aggression
  • 4 warnings on stimulants causing seizures
  • 3 warnings on stimulants causing agitation or irritability
  • 3 warnings on stimulants causing anxiety
  • 2 warnings on stimulants causing suicide risk/attempts
  • 2 warnings on stimulants causing addiction or dependence

ADHD Drug Studies:

There are 25 studies from five countries (United States, Australia, Denmark, Canada and Italy) showing that ADHD drugs/stimulants cause harmful side effects. These include the following (note that some studies cite more than one side effect, so the list below may not be equal to the total number of studies):

  • 5 studies on stimulants causing addiction/medication abuse
  • 5 studies on stimulants causing heart problems
  • 5 studies on stimulants showing lack of efficacy of the drug
  • 4 studies on stimulants causing stunted growth
  • 2 studies on stimulants causing death
  • 1 study on stimulants causing suicide risk/attempts
  • 1 study on stimulants causing violence
  • 1 study on stimulants causing homicidal ideation
  • 1 study on stimulants causing irritability
  • 1 study on stimulants causing depression
  • 1 study on stimulants causing mania, psychosis and hallucinations

Isn't it time we examined a drug-free alternative? The CES Ultra is exactly that—a safe and effective modality with no negative side-effect